Market Research Logo

Anemia Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Anemia Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

A recent market study published by FMI, titled 'Anemia Treatment Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028', consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the anemia treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the anemia treatment market during the forecast period. It can help players modify their manufacturing and marketing strategies to envisage maximum growth in the anemia treatment market in the coming years. The report provides detailed information about the current and future growth prospects of the anemia treatment market in the most comprehensive way for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the anemia treatment market, which includes the summary of key findings and key statistics of the market. It also includes market value (US$ million) estimates of the leading segments of the anemia treatment market.

Chapter 2 – Market Introduction

Readers can find detailed taxonomy and definition of the anemia treatment market in this chapter, which will help them understand the basic information about the anemia treatment market.

Chapter 3 – Market Opportunity Analysis

This chapter explains the key macro-economic factors that are expected to influence the growth of the anemia treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the anemia treatment market. It helps readers understand the market opportunities, based on which they can plan their strategies.

Chapter 4 – Market Background

This chapter highlights the key dynamics of the anemia treatment market, which includes the drivers, restraints, and trends. The supply-side drivers as well as demand-side drivers of the anemia treatment market are explained in this chapter. This chapter is expected to enable readers to understand the factors that are propelling the growth of the anemia treatment market, as well as those that are likely to hamper the growth of the anemia treatment market. Moreover, readers will understand the key trends followed by leading manufacturers in the anemia treatment market.

Chapter 5 – Global Economic Outlook

This section highlights the healthcare spending of the top countries in each region. It also explains the global and regional healthcare market outlook. Regional healthcare markets are analyzed in depth to assess the political, economic, and business environment outlook of respective regions.

Chapter 6 – Key Inclusions

This chapter highlights the key inclusions of the anemia treatment market report, which includes regional pricing analysis, epidemiology-based scenario by region, regulatory guidelines, and list of manufacturers.

Chapter 7 – North America Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

This chapter includes detailed analysis of the growth of the North America anemia treatment market, along with country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on treatment, disease, route of administration, distribution channel, and country in the North American market.

Chapter 8 – Latin America Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Readers can find detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the Latin America anemia treatment market. This chapter also includes the growth prospects of the anemia treatment market in leading LATAM countries/regions such as Brazil, Mexico, and the Rest of Latin America.

Chapter 9 – Europe Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the anemia treatment market based in several European countries/regions, such as EU4, Spain, Russia, and the Rest of Europe are included in this chapter.

Chapter 10 – East Asia Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Detailed information about factors such as incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of the East Asia anemia treatment market are included in this chapter. It also includes the growth prospects of the anemia treatment market in leading East Asian countries such as China, Japan, and South Korea.

Chapter 11 – South Asia Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

India, Indonesia, Malaysia, Thailand, and the Rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia anemia treatment market, in this chapter. Readers can find thorough information about the growth parameters of the South Asia anemia treatment market during the period 2018-2028.

Chapter 12 – Oceania Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

This chapter consists of important parameters that have a huge impact on the growth of the anemia treatment market in Oceania, based on market segmentation, during the forecast period. This chapter also provides an overview of the drivers, restraints, and trends in the Oceania anemia treatment market.

Chapter 13 – MEA Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the anemia treatment market based in several MEA countries/regions such as GCC Countries, South Africa, and the Rest of MEA are included in this chapter.

Chapter 14 – Emerging Nations Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

Important growth prospects of the anemia treatment market in emerging nations such as China, India, and Brazil are included in this chapter.

Chapter 15 – Forecast Factors: Relevance and Impact

This chapter highlights the key factors that are taken into consideration while forecasting the market value of the global anemia treatment market. The impact of these forecast factors in different regions is also mentioned in this chapter.

Chapter 16 – Forecast Assumptions

This section provides the relevant factors and their impact on the market that were taken into consideration to build the market for the current year 2017 and make the market forecast (2018–2028). It will help readers gain more information and know which factors play a key role in shaping the present and future of the market.

Chapter 17 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the anemia treatment market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the report include Amgen Inc., Hoffmann-La Roche Ltd, Pfizer Inc., Novartis AG, Janssen Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd, AMAG Pharmaceuticals, Rockwell Medical, and Akebia Therapeutics, among others.

Chapter 18 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Region

This chapter explains how the anemia treatment market will grow across various geographic regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA), and Emerging Nations.

Chapter 19 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Treatment

Based on treatment, the anemia treatment market is segmented into medications and dietary supplements. In this chapter, readers can find detailed analysis of the anemia treatment market by different treatment types, and their expected growth over the forecast period.

Chapter 20 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Disease

Based on disease, the anemia treatment market is segmented into normocytic anemia, microcytic anemia, and macrocytic anemia. This section helps readers understand the penetration of the anemia treatment market based on these diseases, over the forecast period.

Chapter 21 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Route of Administration

Based on route of administration, the global anemia treatment market can be classified into injectable route and oral route. In this chapter, readers can understand the market attractive analysis based route of administration.

Chapter 22 – Global Anemia Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028 by Distribution Channel

Based on distribution channel, the global anemia treatment can be classified into institutional pharmacies, retail pharmacies, and mail-order pharmacies. In this chapter, readers can understand the market attractive analysis based on distribution channel.

Chapter 23 – Global Anemia Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028

This section explain the global market analysis and forecast of the anemia treatment market. It also highlights the incremental opportunity for the anemia treatment market, along with absolute dollar opportunity for every year during the forecast period of 2018-2028.

Chapter 24 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 25 – Research Methodology

This chapter helps readers understand the research methodology that has been followed to obtain various conclusions, important qualitative information, and quantitative information about the anemia treatment market.


1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Anemia Epidemiology, By Key Countries
3.2. Product Innovation / Key Development Trends
3.3. New Launches and other trends
4. Key Success Factors
4.1. Anemia Diagnosis Trend Analysis
4.2. Global Anemia Treatment Seeking Rate
4.3. Drug Pipeline Assessment
5. Global Anemia Treatment Market - Pricing Analysis
5.1. Regional Pricing Analysis By Treatment
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6. Global Anemia Treatment Market Analysis 2013-2017 and Forecast, 2018-2028
6.1. Historical Market Value (US$ Mn) Analysis, 2013-2017
6.2. Current and Future Market Value (US$ Mn) Projections, 2018-2028
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Market Background
7.1. Macro-Economic Factors
7.1.1. Gross Domestic Product by Region & Country, 2006 – 2021
7.1.2. Global Healthcare Expenditure Outlook
7.2. Forecast Factors - Relevance & Impact
7.2.1. Anemia Prevalence and Growth
7.2.2. Per-Capita Healthcare Expenditure
7.2.3. Treatment Seeking Rate
7.2.4. Prescription Rate and Drug Penetration
7.2.5. Per Patient Spending
7.3. Value Chain
7.4. Market Dynamics
7.4.1. Drivers
7.4.2. Restraints
7.4.3. Opportunity Analysis
8. Global Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Treatment Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Treatment, 2013 - 2017
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment, 2018 - 2028
8.3.1. Microcytic Anemia (Low MCV)
8.3.1.1. Iron deficiency anemia
8.3.1.2. Thalassemia
8.3.1.3. Sideroblastic anemia
8.3.2. Normocytic Anemia (Normal MCV)
8.3.2.1. Blood loss Anemia
8.3.2.2. Sickle cell anemia
8.3.2.3. Anemia due to chronic disease
8.3.2.4. Aplastic Anemia
8.3.3. Macrocytic Anemia (High MCV)
8.3.3.1. Vitamin deficiency anemia
8.4. Market Attractiveness Analysis By Treatment
9. Global Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Disease Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Disease Type, 2013 - 2017
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2018 - 2028
9.3.1. Microcytic Anemia (Low MCV)
9.3.1.1. Iron deficiency Anemia
9.3.1.2. Thalassemia
9.3.1.3. Sideroblastic Anemia
9.3.2. Normocytic Anemia (Normal MCV)
9.3.2.1. Blood loss Anemia
9.3.2.2. Sickle cell anemia
9.3.2.3. Anemia due to Chronic disease
9.3.2.4. Aplastic Anemia
9.3.3. Macrocytic Anemia (High MCV)
9.3.3.1. Vitamin deficiency Anemia
9.4. Market Attractiveness Analysis By Disease Type
10. Global Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Route of Administration
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2013 - 2017
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration 2018 – 2028
10.3.1. Oral Route
10.3.2. Injectable Route
10.4.Market Attractiveness Analysis By Route of Administration
11. Global Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2017
11.3. Current and Future Market Size (US$ Mn) Analysis and Distribution Channel 2018 – 2028
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Mail-order Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2017
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Middle East and Africa (MEA)
12.3.5. East Asia
12.3.6. South Asia
12.3.7. Oceania
12.4. Market Attractiveness Analysis By Region
13. North America Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
13.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.2. By Treatment Type
13.4.3. By Distribution Channel
13.5. Market Attractiveness Analysis
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. Latin America Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
14.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Argentina
14.4.1.4. Rest of Latin America
14.4.2. By Treatment Type
14.4.3. By Distribution Channel
14.5. Market Attractiveness Analysis
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. Europe Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
15.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. Italy
15.4.1.3. France
15.4.1.4. U.K.
15.4.1.5. Spain
15.4.1.6. BENELUX
15.4.1.7. Russia
15.4.1.8. Rest of Europe
15.4.2. By Treatment Type
15.4.3. By Distribution Channel
15.5. Market Attractiveness Analysis
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. East Asia Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.2. By Treatment Type
16.4.3. By Distribution Channel
16.5.Market Attractiveness Analysis
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. South Asia Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Treatment Type
17.4.3. By Distribution Channel
17.5. Market Attractiveness Analysis
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Oceania Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
18.4.1. By Country
18.4.1.1. Australia
18.4.1.2. New Zealand
18.4.2. By Treatment Type
18.4.3. By Distribution Channel
18.5. Market Attractiveness Analysis
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
19.4.1. By Country
19.4.1.1. GCC Countries
19.4.1.2. South Africa
19.4.1.3. Rest of Middle East and Africa
19.4.2. By Treatment Type
19.4.3. By Distribution Channel
19.5. Market Attractiveness Analysis
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
20. Emerging Countries Anemia Treatment Market Analysis 2013-2017 and Forecast 2018-2028
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. China Anemia Treatment Market Analysis
20.2.1. Introduction
20.2.2. Market Value Proportion Analysis by Market Taxonomy
20.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.2.3.1. By Treatment Type
20.2.3.2. By Distribution Channel
20.2.4. China Anemia Treatment Market - Competition Landscape
20.3. India Anemia Treatment Market Analysis
20.3.1. Introduction
20.3.2. Market Value Proportion Analysis by Market Taxonomy
20.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.3.3.1. By Treatment Type
20.3.3.2. By Distribution Channel
20.3.4. India Anemia Treatment Market - Competition Landscape
20.4. Brazil Anemia Treatment Market Analysis
20.4.1. Introduction
20.4.2. Market Value Proportion Analysis by Market Taxonomy
20.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.4.3.1. By Treatment Type
20.4.3.2. By Distribution Channel
20.4.4. Brazil Treatment Market - Competition Landscape
21. Competition Analysis
21.1. Competition Dashboard
21.2. Pricing Analysis by Competition
21.3. Competition Benchmarking
21.4. Competition Deep Dive
21.4.1. Amgen Inc
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. Sales Footprint
21.4.1.4. Analyst commentary
21.4.2. Hoffmann-La Roche Ltd
21.4.3. Novartis AG
21.4.4. Pfizer Inc
21.4.5. Janssen Pharmaceuticals, Inc.
21.4.6. Teva Pharmaceutical Industries Ltd,
21.4.7. AMAG Pharmaceuticals
21.4.8. Rockwell Medical
21.4.9. Akebia Therapeutics
21.4.10. Vifor Pharma Management Ltd.
22. Assumptions and Acronyms Used
23. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report